Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/10/meoh-stock-jumps-as-earnings-beat-fuels-buyback-momentum.jpg

MEOH Stock Jumps As Earnings Beat Fuels Buyback Momentum

TIM BOHEN•UPDATED OCT. 30, 2026, 12:33 PM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

Methanex Corporation’s stocks have been trading up by 13.73 percent amid upbeat sentiment around stronger methanol demand and pricing.

Key Takeaways

  • Q3 earnings smashed expectations with adjusted EPS of $3.69 vs. $2.86 and revenue of $1.39B vs. $1.3B on record North American methanol production and tight global supply.
  • Net income and cash flow climbed, and MEOH guided to even higher realized prices and EBITDA in Q4 despite idling capacity in New Zealand and Trinidad.
  • CIBC lifted its Methanex price target to $77 and UBS to $74, both sticking with bullish ratings as they bake in stronger methanol pricing.
  • The board approved a Normal Course Issuer Bid to repurchase up to 3.87M shares (5% of float) from 2026/11/04 to 2027/11/03, supported by strong operations and deleveraging.

Candlestick Chart

Get Free Alerts

Live Update At 12:32:22 EDT: On Friday, October 30, 2026 Methanex Corporation stock [NASDAQ: MEOH] is trending up by 13.73%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

MEOH has been trading like a momentum name since the Q3 numbers hit. On the daily chart, Methanex shares ripped from the low $60s to close near $71.20, with the latest session’s range stretching from $66.00 to $71.41. That is a clean breakout move after several sessions chopping between roughly $60 and $65.

Intraday, the 5‑minute chart shows MEOH holding higher lows through the session, shaking out early volatility around $67, then grinding above $70 and consolidating near the highs. That tells traders dip buyers were in control, not day‑trade flippers dumping into every pop.

More Breaking News

Under the hood, Methanex posted Q3 revenue of about $1.39B, well ahead of consensus, on strong methanol pricing and record North American production. EBITDA reached $579.46M, backing up the price action with real cash generation. Free cash flow for the recent period ran at roughly $731.40M, a big number versus the current enterprise value of about $4.66B. For active traders, that kind of cash machine plus a confirmed breakout is exactly the combo that can keep MEOH on watch lists.

Why Traders Are Watching MEOH Right Now

The core story is simple: MEOH used a tight methanol market to print a serious earnings beat. Adjusted EPS came in at $3.69 versus the $2.86 consensus, while revenue hit $1.39B against expectations around $1.30B. Methanex credits record North American methanol output and tight global supply, helped by Middle East conflict disruptions. When a commodity player rides both volume and price at the same time, traders pay attention.

Beyond the headline beat, Methanex told the market to expect even higher realized prices and EBITDA in Q4 2026. That matters. It shifts the narrative from “one‑off spike” to “ongoing run,” at least in the near term. MEOH also started deleveraging via bond redemptions, an important counterweight for anyone worried about the company’s 1.22 debt‑to‑equity ratio.

Analysts have moved in the same direction. CIBC Capital Markets pushed its MEOH price target to $77 from $71, keeping an Outperformer rating and lifting 2026–2027 EBITDA estimates by 8–9% on the back of stronger methanol pricing tied to supply disruptions. UBS followed with a target hike to $74 and a reiterated Buy, with the broader street sitting overweight and an average target near $69.36. For short‑term trading, that kind of clustered bullish research can act as fuel on any breakout.

Layer on top the Normal Course Issuer Bid. Methanex’s board authorized buybacks of up to 3.87M shares, about 5% of the float, between 2026/11/04 and 2027/11/03. For chart‑focused traders, consistent repurchases can create a bid underneath the stock, supporting MEOH on pullbacks and adding a slow‑burn squeeze effect over time.

Conclusion

For active traders who live and die by catalysts, MEOH is checking multiple boxes at once. Methanex just delivered a clean earnings and revenue beat, threw off strong cash flow, and pointed to even better pricing and EBITDA in the next quarter. The stock has responded with a breakout from the $60 area to the low $70s on strong intraday action. That is the kind of price–volume confirmation experienced traders look for.

At the same time, Methanex is not just riding the cycle. Management is shrinking share count through a 5% Normal Course Issuer Bid, paying a modest dividend, and starting to chip away at debt. Medium‑term production guidance of 9.0M tons of methanol and 0.3M tons of ammonia suggests MEOH expects to keep plants busy and cash flowing, even as some New Zealand and Trinidad capacity gets idled.

For the Tim Sykes‑style community, the playbook is familiar: respect the catalyst, respect the trend, and never marry the stock. As Tim Sykes likes to remind traders, “Patterns repeat, but outcomes never come with guarantees — that’s why you stay disciplined, trade the plan, and cut losses quickly.” That mentality lines up closely with the momentum‑driven approach many short‑term day traders follow today; as Tim Bohen, lead trainer with StocksToTrade says, “I focus on momentum that’s visible right now. Speculation on future moves is outside my playbook.” MEOH now sits in that sweet spot where strong fundamentals, favorable commodity dynamics, and aggressive capital returns line up — but as always, traders need their own plan and risk rules before jumping in.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders